Résultats de recherche
19 Mars 2026 - 2 mn de lecture
Purpose‑driven partnering: choosing programs where our approach makes the greatest impact
Nick Gagnon, Vice President and Head of Late Stage Partnering...
19 Mars 2026 - 2 mn de lecture
Partenariats guidés par la raison d’être : choisir les programmes où notre approche génère le plus grand impact
Nick Gagnon, Vice-Président et Responsable des Partenariats en Phase Avancée...
19 Septembre 2025 - 2 mn de lecture
19 Septembre 2025 - 3 mn de lecture
08 Juin 2026 - 2 mn de lecture
Biopharma deals thrive on creativity, from structure through to execution
Philippe Lopes‑Fernandes, Chief Business Officer ...
05 Juin 2026 - 2 mn de lecture
12 Septembre 2024 - 4 mn de lecture
Partnering for Progress: The Importance of Collaboration in Primary Biliary Cholangitis (PBC) Awareness
Sandra Silvestri, Executive Vice President & Chief Medical Officer at Ipsen, reflects on the theme for this year’s PBC Awareness Day, what living with PBC really means, and the power of collaborating with patient organizations to help drive progress ...
28 Octobre 2024 - 2 mn de lecture
Science-First Collaborations: Ipsen’s Blueprint to External Innovation
David Jenkins, SVP and Head of External Innovation and Research, leads efforts to identify, evaluate and secure new programs across Ipsen’s three strategic areas of Oncology, Rare disease, and Neuroscience. He shares his insights on the essential role th...
28 Octobre 2024 - 3 mn de lecture
Collaborations scientifiques : le modèle d’Ipsen en matière d’innovation externe
David Jenkins, Vice-Président Senior, à la tête du département Recherche & Innovation Externe, est responsable des activités visant à identifier, évaluer et ajouter au portefeuille d’Ipsen de nouveaux programmes dans les trois aires thérapeut...
22 Avril 2024 - 3 mn de lecture
Navigating Proactive Sustainability in Pharma R&D and Partnering
In March, we were proud to see Florence Dal Degan, Senior Director of External Innovation, participate in a panel discussion with different stakeholders, from consulting firms, pharma companies, investors to startups at BioEurope Spring entitled "Towards a...